0.3559
price down icon9.92%   -0.0392
pre-market  Vorhandelsmarkt:  .38   0.0241   +6.77%
loading
Schlusskurs vom Vortag:
$0.3951
Offen:
$0.3578
24-Stunden-Volumen:
11.64M
Relative Volume:
1.63
Marktkapitalisierung:
$52.16M
Einnahmen:
$49.09M
Nettoeinkommen (Verlust:
$-52.15M
KGV:
-0.5475
EPS:
-0.65
Netto-Cashflow:
$-45.93M
1W Leistung:
+61.77%
1M Leistung:
-27.37%
6M Leistung:
-72.20%
1J Leistung:
-76.59%
1-Tages-Spanne:
Value
$0.3425
$0.3995
1-Wochen-Bereich:
Value
$0.22
$0.5147
52-Wochen-Spanne:
Value
$0.1718
$2.04

Biodesix Inc Stock (BDSX) Company Profile

Name
Firmenname
Biodesix Inc
Name
Telefon
303-417-0500
Name
Adresse
919 WEST DILLON ROAD, LOUISVILLE
Name
Mitarbeiter
273
Name
Twitter
Name
Nächster Verdiensttermin
2025-03-03
Name
Neueste SEC-Einreichungen
Name
BDSX's Discussions on Twitter

Vergleichen Sie BDSX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Diagnostics & Research icon
BDSX
Biodesix Inc
0.3559 32.24M 49.09M -52.15M -45.93M -0.65
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
400.48 152.86B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
187.48 136.66B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
504.83 41.18B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
109.68 32.05B 6.53B 1.26B 1.31B 4.35
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
138.04 24.29B 15.50B 1.33B 2.16B 7.34

Biodesix Inc Stock (BDSX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-05-14 Herabstufung William Blair Outperform → Mkt Perform
2024-09-16 Eingeleitet Scotiabank Sector Outperform
2024-07-26 Eingeleitet Craig Hallum Buy
2024-05-13 Eingeleitet TD Cowen Buy
2024-05-03 Eingeleitet Lake Street Buy
2021-11-17 Herabstufung Morgan Stanley Overweight → Equal-Weight
2020-11-23 Eingeleitet BTIG Research Buy
2020-11-23 Eingeleitet Canaccord Genuity Buy
2020-11-23 Eingeleitet Morgan Stanley Overweight
2020-11-23 Eingeleitet William Blair Outperform
Alle ansehen

Biodesix Inc Aktie (BDSX) Neueste Nachrichten

pulisher
May 22, 2025

Biodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual Meeting | BDSX Stock News - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Biodesix to Present New Data on Host Immune Classifier for NSCLC at 2025 ASCO Annual Meeting - Nasdaq

May 22, 2025
pulisher
May 22, 2025

Biodesix Announces New Data on the VeriStrat® Test to be Presented at the 2025 ASCO Annual Meeting - GlobeNewswire

May 22, 2025
pulisher
May 22, 2025

Game-Changing Cancer Test Triples Survival Rate: New Clinical Data Transforms Lung Cancer Treatment - Stock Titan

May 22, 2025
pulisher
May 22, 2025

Biodesix (BDSX) Target Price Reduced to $2 by Scotiabank | BDSX Stock News - GuruFocus

May 22, 2025
pulisher
May 21, 2025

Biodesix Jumps 46% As Insider Buying, Retail Optimism Offset Scotiabank Target Cut By Stocktwits - Investing.com India

May 21, 2025
pulisher
May 21, 2025

Scotiabank cuts Biodesix stock target to $2, maintains outlook By Investing.com - Investing.com Canada

May 21, 2025
pulisher
May 21, 2025

Biodesix Approves Reverse Stock Split at Annual Meeting - TipRanks

May 21, 2025
pulisher
May 21, 2025

Scotiabank cuts Biodesix stock target to $2, maintains outlook - Investing.com

May 21, 2025
pulisher
May 21, 2025

Biodesix (BDSX) Sees Target Price Lowered by Scotiabank | BDSX S - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Biodesix to Participate in Upcoming Investor Conferences | BDSX Stock News - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Biodesix to Participate in Upcoming Investor Conferences - GlobeNewswire

May 21, 2025
pulisher
May 21, 2025

Biodesix Executives Set for Major Investor Conferences: William Blair and Craig-Hallum Presentations Ahead - Stock Titan

May 21, 2025
pulisher
May 20, 2025

Director’s Massive Stock Purchase Signals Confidence in Biodesix! - TipRanks

May 20, 2025
pulisher
May 19, 2025

Biodesix's (BDSX) "Market Perform" Rating Reaffirmed at William Blair - MarketBeat

May 19, 2025
pulisher
May 17, 2025

Craig Hallum Cuts Biodesix (NASDAQ:BDSX) Price Target to $1.50 - Defense World

May 17, 2025
pulisher
May 16, 2025

Biodesix revises 2025 revenue guidance to $80M–$85M amid sales force reconfiguration and primary care expansion - MSN

May 16, 2025
pulisher
May 16, 2025

Susquehanna International Group LLP Grows Stock Holdings in Biodesix, Inc. (NASDAQ:BDSX) - MarketBeat

May 16, 2025
pulisher
May 16, 2025

Biodesix, Inc. (NASDAQ:BDSX) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - Yahoo Finance

May 16, 2025
pulisher
May 15, 2025

Biodesix, Inc. Earnings Call: Growth Amid Challenges - TipRanks

May 15, 2025
pulisher
May 15, 2025

Biodesix, Inc. (NASDAQ:BDSX) Q1 2025 Earnings Call Transcript - MSN

May 15, 2025
pulisher
May 15, 2025

Analysts Just Slashed Their Biodesix, Inc. (NASDAQ:BDSX) EPS Numbers - simplywall.st

May 15, 2025
pulisher
May 15, 2025

Biodesix Announces New Clinical and Economic Data for Its Nodify Lung® Tests At ISPOR and ATS - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

News Flash: 6 Analysts Think Biodesix, Inc. (NASDAQ:BDSX) Earnings Are Under Threat - Yahoo Finance

May 15, 2025
pulisher
May 15, 2025

Biodesix Announces New Clinical and Economic Data for its Nodify Lung® Tests at ISPOR and ATS | BDSX Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Biodesix, Inc. to Present New Data on Lung Cancer Diagnosis and Testing at ISPOR and ATS 2025 Conferences - Nasdaq

May 15, 2025
pulisher
May 15, 2025

Biodesix Announces New Clinical and Economic Data for its Nodify Lung® Tests at ISPOR and ATS - GlobeNewswire

May 15, 2025
pulisher
May 15, 2025

New Clinical Data: Biodesix Lung Cancer Tests Could Prevent 60% of Unnecessary Invasive Procedures - Stock Titan

May 15, 2025
pulisher
May 15, 2025

Denver Post Names Biodesix a Winner of Top Workplaces 2025 Award - GlobeNewswire

May 15, 2025
pulisher
May 14, 2025

Biodesix Stock: A Deep Dive Into Analyst Perspectives (4 Ratings) - Benzinga

May 14, 2025
pulisher
May 14, 2025

Craig-Hallum Adjusts Price Target for Biodesix (BDSX) | BDSX Sto - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Diagnostic Leader Biodesix Clinches Elite Colorado Workplace Award, Employee Survey Reveals Why - Stock Titan

May 14, 2025
pulisher
May 14, 2025

Biodesix stock plunges as life-sciences firm cuts sales projection - BizWest

May 14, 2025
pulisher
May 14, 2025

Biodesix (BDSX): Analyst Maintains Buy Rating Despite Lowered Pr - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Biodesix (BDSX) Target Price Lowered by Lake Street Analyst | BD - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Canaccord cuts Biodesix stock target to $1.50, keeps buy rating By Investing.com - Investing.com Nigeria

May 14, 2025
pulisher
May 14, 2025

Biodesix stock target cut to $2 by TD Cowen, retains buy rating - Investing.com

May 14, 2025
pulisher
May 14, 2025

Biodesix, Inc. (BDSX) Reports Q1 Loss, Misses Revenue Estimates - MSN

May 14, 2025
pulisher
May 14, 2025

Biodesix (BDSX) Target Price Lowered by Lake Street Analyst | BDSX Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Biodesix Inc Reports Q1 2025 Earnings: EPS of -$0.08 Misses Esti - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Biodesix stock rating cut to Market Perform at William Blair By Investing.com - Investing.com South Africa

May 14, 2025
pulisher
May 14, 2025

BDSX: Canaccord Genuity Lowers Price Target for Biodesix | BDSX Stock News - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Canaccord cuts Biodesix stock target to $1.50, keeps buy rating - Investing.com Australia

May 14, 2025
pulisher
May 14, 2025

BDSX Reports Q1 Revenue Below Expectations, Highlights Strategic - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Biodesix price target lowered to $1.50 from $2.50 at Canaccord - TipRanks

May 14, 2025
pulisher
May 14, 2025

Biodesix (BDSX) Price Target Reduced as 2025 Revenue Outlook Dec - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Biodesix price target lowered to $1.50 from $3 at Craig-Hallum - TipRanks

May 14, 2025
pulisher
May 14, 2025

Biodesix price target lowered to $2 from $3 at TD Cowen - TipRanks

May 14, 2025
pulisher
May 14, 2025

Biodesix (BDSX) Downgraded to Market Perform by William Blair | - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Biodesix (BDSX) Target Price Reduced to $2 Amid Revenue Challeng - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Biodesix (BDSX) Price Target Reduced as 2025 Revenue Outlook Declines | BDSX Stock News - GuruFocus

May 14, 2025

Finanzdaten der Biodesix Inc-Aktie (BDSX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
diagnostics_research DGX
$169.62
price down icon 0.50%
diagnostics_research LH
$241.89
price up icon 0.23%
diagnostics_research WAT
$348.46
price up icon 0.32%
$152.48
price up icon 0.92%
diagnostics_research MTD
$1,136.00
price up icon 0.24%
diagnostics_research IQV
$138.04
price up icon 0.55%
Kapitalisierung:     |  Volumen (24h):